Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 5301 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 26 |
| 5302 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 52 |
| 5303 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 38 |
| 5304 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 5305 | Apheresis | Allogeneic | Acute Myeloid Leukemia – Relapse | Hematology | 2019 | Standard Therapy | Germany | 51 |
| 5306 | Apheresis | Autologous | Amyloidosis | Hematology | 2019 | Standard Therapy | Germany | 60 |
| 5307 | Apheresis | Allogeneic | Aplasia | Hematology | 2019 | Standard Therapy | Poland | 51 |
| 5308 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 5309 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 5310 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 46 |
| 5311 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 21 |
| 5312 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 28 |
| 5313 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 5314 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 5315 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 5316 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 5317 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 5318 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 5319 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5320 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 5321 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5322 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 5323 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 5324 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
| 5325 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 34 |
| 5326 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
| 5327 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 56 |
| 5328 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 5329 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 56 |
| 5330 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 31 |
| 5331 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 5332 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 5333 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 5334 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5335 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 73 |
| 5336 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 5337 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 5338 | Apheresis | Autologous | Embryonal Cell Carcinoma Of The Testicle | Hematology | 2019 | Standard Therapy | Germany | 29 |
| 5339 | Apheresis | Allogeneic | Extracranial Malignant Germ Cell Tumors | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 5340 | Apheresis | Allogeneic | Glanzmann Thrombasthenia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 5341 | Apheresis | Allogeneic | High-Risk Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 5342 | Apheresis | Allogeneic | Histiocytosis X | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 5343 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5344 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 5345 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 28 |
| 5346 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 44 |
| 5347 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 5348 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 32 |
| 5349 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 34 |
| 5350 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 5351 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 5352 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 5353 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 5354 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 5355 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 5356 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 5357 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 5358 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 54 |
| 5359 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 5360 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 5361 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 5362 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 71 |
| 5363 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 5364 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 5365 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
| 5366 | Apheresis | Autologous | Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy | Hematology | 2019 | Standard Therapy | Germany | 36 |
| 5367 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 5368 | Apheresis | Allogeneic | Mucopolysaccharidosis Type I | Metabolic | 2019 | Standard Therapy | Poland | 1 |
| 5369 | Apheresis | Allogeneic | Mucopolysaccharidosis Type Ii | Metabolic | 2019 | Standard Therapy | Poland | 2 |
| 5370 | Apheresis | Allogeneic | Mucopolysaccharidosis Type Ii | Metabolic | 2019 | Standard Therapy | Poland | 2 |
| 5371 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Poland | 52 |
| 5372 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 5373 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 5374 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 5375 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 5376 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 69 |
| 5377 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 5378 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 5379 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
| 5380 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 5381 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 54 |
| 5382 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 51 |
| 5383 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
| 5384 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
| 5385 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 61 |
| 5386 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 5387 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 5388 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 5389 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 39 |
| 5390 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
| 5391 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 5392 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 5393 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 40 |
| 5394 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
| 5395 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 53 |
| 5396 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 5397 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 70 |
| 5398 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 5399 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 5400 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 63 |